1. Australia Stocks

  2. •

    Health technology

  3. •

    Biotechnology
Identifai Genetics Limited

Identifai Genetics Limited

AASX:ID1
0.49
AUD
-0.01
(-3.00%)
No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Semi-annual Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Semi-annual Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Semi-annual Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

Company Profile APIChatGPT
CEO
Eyal Miller
Sector
Health technology
Industry
Biotechnology
Address
295 Rokeby Road Subiaco WA Australia 6008
IPO Date
Oct 9, 2026
Website
identifai-genetics.com
Similar Companies
Moderna, Inc. (NASDAQ:MRNA)
Amgen Inc. (NASDAQ:AMGN)
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Novavax, Inc. (NASDAQ:NVAX)
10x Genomics, Inc. (NASDAQ:TXG)
Business
IdentifAI Genetics Ltd. engages in the development, validation, and commercial validation of a genome-wide non-invasive prenatal screening platform. The company was founded by Noam Shomron, Tom Rabinowitz, Oren Tadmor, Kobi Caspi, and Yoseph Bornstein on April 12, 2021 and is headquartered in Subiaco, Australia.